Genomic sequencing experts at Johns Hopkins partnered with
pharmacologists at Stony Brook University to reveal a striking mutational signature of upper urinary tract cancers caused by aristolochic acid, a plant compound contained in herbal remedies used for thousands of years to
treat a variety of ailments such as arthritis, gout and inflammation.